To elucidate the autophagic impairments underlying AD and T2DM, Jung et al. compared tau pathology and its associated signaling pathways in diabetic OLEF rats and age-matched non-diabetic controls (Jung et al., 2011). This evidence concerns the gene MAPT and type 2 diabetes mellitus.